Zim Laboratories Financial Statements
Quarterly
Yearly
| Particulars | Dec '20 | Mar '21 | Jun '21 | Sep '21 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | 74.91 | 73.85 | 64.17 | 77.47 | 86.72 |
| Expenses | 71.27 | 69.08 | 62.56 | 71.56 | 79.87 |
| EBITDA | 3.64 | 4.77 | 1.61 | 5.91 | 6.85 |
| EBIT | -0.27 | 0.58 | -2.05 | 1.55 | 3.02 |
| Profit Before Tax | 1.98 | 2.67 | 0.29 | 4.20 | 5.78 |
| Net Profit | 1.29 | 1.55 | 0.19 | 3.26 | 4.07 |
| Financial Ratios | |||||
| Operating Profit Margin | 4.85% | 6.46% | 2.51% | 7.63% | 7.90% |
| Net Profit Margin | 1.72% | 2.10% | 0.30% | 4.21% | 4.69% |
| Earning Per Share (Diluted) | 0.80 | 0.96 | 0.12 | 2.00 | 2.51 |
| Dividends Per Share | NA | NA | NA | NA | NA |
